Please login to the form below

Not currently logged in

Eli Lilly promotes Anat Ashkenazi to chief financial officer

Ashkenazi previously served as CFO of Lilly Research Laboratories

Eli Lilly has appointed Anat Ashkenazi (pictured above) as chief financial officer (CFO) and senior vice president of the company.

Most recently, Ashkenazi served as senior vice president, controller and CFO of Lilly Research Laboratories.

She has worked at Lilly for almost 20 years, having served in her most recent role at Lilly Research Laboratories since 2016.

In this role, Ashkenazi oversaw the CFOs of the company’s commercial businesses and those for research and development, manufacturing and quality and G&A functions.

During this time, she also led the corporate strategic planning team and business transformation office.

Prior to this, she served as CFO for across a number of Lilly’s global business areas.

"We are confident in Anat's ability to serve as our next CFO given her impeccable track record of leadership and business success across nearly all major parts of the company, most recently as corporate controller and head of strategy,” said David Ricks, chairman and chief executive officer of Lilly.

Ashkenazi succeeds Josh Smiley in the CFO role, who has resigned from the post and is set to leave the company.

Article by
Lucy Parsons

10th February 2021

From: Marketing



Subscribe to our email news alerts


Add my company
Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...